39.83
BATS BZX Real-Time Price
As of 11:19am ET
 +0.155 / +0.39%
Today’s Change
34.38
Today|||52-Week Range
43.30
+4.86%
Year-to-Date
AstraZeneca Gives Detailed Data From Calquence Leukemia Study
10:33am / Zacks.comZAK - Paid Partner Content
Was ASCO Quieter for Big Drug/Biotech Stocks This Year?
Jun 06 / Zacks.comZAK - Paid Partner Content
Keytruda & 4 Other Reasons to Invest in Merck's (MRK) Stock
Jun 13 / Zacks.comZAK - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Merck
Jun 06 / MotleyFool.comFOO - Paid Partner Content
The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca
Jun 10 / Zacks.comZAK - Paid Partner Content
Cancer-Fighting Stocks & ETF: What You Need to Know
Jun 05 / Zacks.comZAK - Paid Partner Content
Here's My Top Stock to Buy in June
Jun 09 / MotleyFool.comFOO - Paid Partner Content
Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options
Jun 05 / Zacks.comZAK - Paid Partner Content
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache
Jun 07 / Zacks.comZAK - Paid Partner Content
Why Cancer-Fighting Stocks & ETFs Are Soaring
Jun 03 / Zacks.comZAK - Paid Partner Content

Today’s Trading

Previous close39.67
Today’s open39.59
Day’s range39.57 - 39.83
Volume500,368
Average volume (3 months)4,881,767
Market cap$104.1B
Data as of 11:19am ET, 06/17/2019

Growth & Valuation

Earnings growth (last year)-29.11%
Earnings growth (this year)+2.07%
Earnings growth (next 5 years)+15.10%
Revenue growth (last year)-2.88%
P/E ratio41.9
Price/Sales4.36
Price/Book8.06

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.01+0.02%
GSKGlaxoSmithKline-0.13-0.32%
LLYEli Lilly and Co+0.89+0.80%
NVONovo Nordisk+0.37+0.73%
Data as of 11:19am ET, 06/17/2019

Financials

Next reporting dateOctober 24, 2019
EPS forecast (this quarter)$0.35
Annual revenue (last year)$22.1B
Annual profit (last year)$2.2B
Net profit margin9.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts